SCHEMBL158786

SCHEMBL158786

CCc1cc[c]c(O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4448266 0.83 CNR1 (0.48)
SCHEMBL11134188 0.79 NPC1 (0.50)
SCHEMBL5504193 0.79
SCHEMBL27864547 0.78 PTGS2 (0.50)
SCHEMBL27710067 0.77
SCHEMBL11597445 0.77 PTGS2 (0.52)
SCHEMBL7055467 0.77 PTGS2 (0.52)
SCHEMBL15067982 0.76 TRPA1 (0.39)
SCHEMBL10460435 0.76 KDM4E (0.48)
SCHEMBL455762 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1064 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397366-A2 GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA Ardelyx, Inc. (US) 2024-07-10 EP disclosed
US-20240209019-A1 COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA ARDELYX, INC. (US) 2024-06-27 US disclosed
EP-3682873-B1 SMAC MIMETICS FOR USE IN THE TREATMENT OF PERSISTENT HIV INFECTION WALTER & ELIZA HALL INST MEDICAL RES (AU) 2024-06-12 EP disclosed
US-RE49934-E1 Inhibitors of cellular metabolic processes SERVIER PHARMACEUTICALS LLC (US) 2024-04-23 US disclosed
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2024-04-11 US disclosed
EP-3661945-B1 GLYCYRRHETINIC ACID DERIVATIVES FOR TREATING HYPERKALEMIA ARDELYX INC (US) 2024-04-03 EP disclosed
US-11858959-B2 Glycyrrhetinic acid derivatives for use in treating hyperkalemia ARDELYX, INC. (US) 2024-01-02 US disclosed
US-20230390246-A1 Compounds and Compositions That Bind and Stabilize Transthyretin and Their Use for Inhibiting Transthyretin Amyloidosis and Protein-Protein Interactions THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2023-12-07 US disclosed
US-11795170-B2 Therapeutic compounds, compositions and methods of use thereof GENENTECH, INC. (US) 2023-10-24 US disclosed
US-11768319-B2 Glycyrrhetinic acid derivatives for treating hyperkalemia ARDELYX, INC. (US) 2023-09-26 US disclosed
EP-0037729-A2 Process for penicillin epimerization ELI LILLY AND COMPANY (US) 1981-10-14 EP disclosed
US-4293493-A Azetidinone alcohol disulfides and process for cyclization ELI LILLY AND COMPANY (US) 1981-10-06 US disclosed
US-4293495-A Symmetrical azetidinone aldehyde disulfides and process ELI LILLY AND COMPANY (US) 1981-10-06 US disclosed
US-4147739-A Thermoplastic molding compositions of rubber modified copolymers of a vinyl aromatic compound and an α,β-unsaturated cyclic anhydride GENERAL ELECTRIC COMPANY (US) 1979-04-03 US disclosed
US-4113797-A BLOCK POLYMERS GENERAL ELECTRIC COMPANY (US) 1978-09-12 US disclosed
US-4077934-A Method of preparing compositions that comprise a polyphenylene ether resin and an alkenyl aromatic resin GENERAL ELECTRIC COMPANY (US) 1978-03-07 US disclosed
US-4060688-A Cephalosporin intermediates ELI LILLY AND COMPANY (US) 1977-11-29 US disclosed
US-4012380-A 7-Acylamino-3-acyl-2(or 3)cephems ELI LILLY AND COMPANY (US) 1977-03-15 US disclosed
US-4001226-A 3-(SUBSTITUTED)CARBONYLAMINO CEPHEM DERIVATIVES ELI LILLY AND COMPANY (US) 1977-01-04 US disclosed
US-3953436-A 3,4-Dicarboxycephalosporins and derivatives ELI LILLY AND COMPANY (US) 1976-04-27 US disclosed